Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression
NCT ID: NCT04912752
Last Updated: 2021-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2020-04-05
2021-01-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load
NCT01924052
Study of the Molecular Genetics of Menstrual Migraine
NCT00904150
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
NCT04592952
Presence of Signs of Central Sensitization in Episodic and Chronic Migraine
NCT05162664
International Headache Registry Study
NCT05418218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case-Control
Copy number variation
Migraine CNV
Copy number variation effect on migraine disease
Case-Control 1
Gene expression
Migraine CNV
Copy number variation effect on migraine disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Migraine CNV
Copy number variation effect on migraine disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Gaziantep
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Şenay Görücü Yılmaz
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehmet Fatih Özaltun, MD
Role: PRINCIPAL_INVESTIGATOR
Assist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medicine
Gaziantep, Şehitkamil, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.